Final In Vivo Bioavailability-Bioequivalence Studies- Analytical
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 1, 2018
December 1, 2018
79269a54-7602-4765-bb0d-fc1bb25d6c42
Related Documents
CDER CDRH Combo Product Compliance Program
Guidance DocumentJune 4, 2020Center for Biologics Evaluation and Research
CHAPTER 48 - 7348809 Bioresearch Monitoring
Guidance DocumentApril 4, 2025Office of Regulatory Affairs
Chapter 48 7348809A Radioactive Drug Research Committee
Guidance DocumentApril 16, 2018Office of Regulatory Affairs
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox